Isolated thrombocytopenia in childhood: what if it is not immune thrombocytopenia?
- PMID: 30109354
- PMCID: PMC6056371
- DOI: 10.11622/smedj.2018089
Isolated thrombocytopenia in childhood: what if it is not immune thrombocytopenia?
Abstract
Introduction: Childhood immune thrombocytopenia (ITP) remains a diagnosis of exclusion when isolated thrombocytopenia is not part of another disease process. In practice, the diagnosis of ITP can only be confirmed when thrombocytopenia resolves or is excluded after the recognition of a primary cause.
Methods: The records of 87 consecutive children with isolated thrombocytopenia seen over a nine-year period in a private paediatric haematology practice were reviewed retrospectively. Children in whom a primary cause was eventually found were the subjects of a further descriptive study.
Results: 9 (10%) children with isolated thrombocytopenia were not diagnosed with ITP because a primary disease was found. Of these nine cases, four had thrombocytopenia recognised during the neonatal period, consisting of perinatal cytomegalovirus infection (n = 2), meconium aspiration pneumonia (n = 1) and transient abnormal myelopoiesis associated with Down syndrome (n = 1). The remaining five children were each found to have familial thrombocytopenia, portal hypertension, cutaneous mastocytosis, May-Hegglin anomaly and systemic lupus erythematosus. Two of them had a history of failure of response to corticosteroid therapy.
Conclusion: Secondary thrombocytopenia is not uncommon in a tertiary paediatric specialty practice with adequate evaluation. Thrombocytopenia occurring during the newborn period and failure of steroid therapy are predictive of secondary cases.
Keywords: differential diagnosis; idiopathic thrombocytopenic purpura; immune thrombocytopenia; neonatal thrombocytopenia; secondary thrombocytopenia.
Copyright: © Singapore Medical Association.
Figures




Comment in
-
Comment on: Isolated thrombocytopenia in childhood: what if it is not immune thrombocytopenia?Singapore Med J. 2018 Sep;59(9):508. doi: 10.11622/smedj.2018113. Singapore Med J. 2018. PMID: 30310920 Free PMC article. No abstract available.
-
Author's reply.Singapore Med J. 2018 Sep;59(9):509. doi: 10.11622/smedj.2018114. Singapore Med J. 2018. PMID: 30310923 Free PMC article. No abstract available.
References
-
- Terrell DR, Beebe LA, Vesely SK, et al. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85:174–80. - PubMed
-
- Neunert C, Lim W, Crowther M, et al. American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207. - PubMed
-
- Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86. - PubMed
-
- Elmas Dal S, Ersoy Y, Ali Erkurt M, et al. An uncommon case of acute brucellosis presenting with severe thrombocytopenia. Intern Med. 2012;51:3291–3. - PubMed
-
- Kumar S, Nair S, Rajam L. Case series of pediatric systemic lupus erythematosus from Kerala: comparison with other Indian series. Int J Rheum Dis. 2010;13:391–5. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources